/Companies

ViCardia Therapeutics

San Francisco, US · Delaware corporation

Find your way into ViCardia Therapeutics

Sign up to see every warm intro you have to ViCardia Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ViCardia Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

MKMichael Kokesh
Michael KokeshPresident & Chief Executive Officer

Reported raises · per SEC filings

Form D private placements

$700K disclosed across 1 round · 2026

▶$700KraisedMay 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael KokeshExecutive Officer
Offering amount
$700K
Amount sold
$700K
Minimum investment
$10K
First sale
May 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has ViCardia Therapeutics raised?
ViCardia Therapeutics has disclosed $700K raised across 1 round.
Where is ViCardia Therapeutics headquartered?
ViCardia Therapeutics is headquartered in San Francisco, US.